Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glycogen synthase kinases: Moonlighting proteins with theranostic potential in cancer
Siddavaram Nagini, Josephraj Sophia, Rajakishore Mishra
Seminars in Cancer Biology (2018) Vol. 56, pp. 25-36
Closed Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Targeting GSK3 and Associated Signaling Pathways Involved in Cancer
Przemysław Duda, Shaw M. Akula, Stephen L. Abrams, et al.
Cells (2020) Vol. 9, Iss. 5, pp. 1110-1110
Open Access | Times Cited: 204
NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism
Douglas B. Fox, Nina Marie G. Garcia, Brock J. McKinney, et al.
Nature Metabolism (2020) Vol. 2, Iss. 4, pp. 318-334
Open Access | Times Cited: 160
Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging
Przemysław Duda, J. Wisniewski, Tomasz Wójtowicz, et al.
Expert Opinion on Therapeutic Targets (2018) Vol. 22, Iss. 10, pp. 833-848
Closed Access | Times Cited: 109
Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer
Josephraj Sophia, Kowshik Jaganathan, Anju Dwivedi, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 11
Open Access | Times Cited: 106
Glycogen Synthase Kinase 3β in Cancer Biology and Treatment
Takahiro Domoto, Masahiro Uehara, Dilireba Bolidong, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1388-1388
Open Access | Times Cited: 87
Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses
İlyas Şahin, Aditya Eturi, André De Souza, et al.
Cancer Biology & Therapy (2019) Vol. 20, Iss. 8, pp. 1047-1056
Open Access | Times Cited: 80
GSK3β as a novel promising target to overcome chemoresistance in pancreatic cancer
Camilla Pecoraro, Beatrice Faggion, Beatrice Balboni, et al.
Drug Resistance Updates (2021) Vol. 58, pp. 100779-100779
Open Access | Times Cited: 69
Immunometabolism in cancer: basic mechanisms and new targeting strategy
Ranran Su, Yingying Shao, Manru Huang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 10
Inhibition of GSK-3β activity suppresses HCC malignant phenotype by inhibiting glycolysis via activating AMPK/mTOR signaling
Guoxu Fang, Peilin Zhang, Jingfeng Liu, et al.
Cancer Letters (2019) Vol. 463, pp. 11-26
Closed Access | Times Cited: 71
Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer
Camilla Evangelisti, Francesca Chiarini, Francesca Paganelli, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2019) Vol. 1867, Iss. 4, pp. 118635-118635
Open Access | Times Cited: 61
FOXO3a knockdown promotes radioresistance in nasopharyngeal carcinoma by inducing epithelial-mesenchymal transition and the Wnt/β-catenin signaling pathway
Min Luo, Cheng Wu, Ergang Guo, et al.
Cancer Letters (2019) Vol. 455, pp. 26-35
Closed Access | Times Cited: 56
Accelerated Bone Regeneration by Astragaloside IV through Stimulating the Coupling of Osteogenesis and Angiogenesis
Feng Wang, Huijuan Qian, Lingchi Kong, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 7, pp. 1821-1836
Open Access | Times Cited: 55
GSK3β: A Master Player in Depressive Disorder Pathogenesis and Treatment Responsiveness
Przemysław Duda, Daria Hajka, Olga Wójcicka, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 727-727
Open Access | Times Cited: 54
Nimbolide, a Neem Limonoid, Is a Promising Candidate for the Anticancer Drug Arsenal
Siddavaram Nagini, Ramesh Nivetha, Manikandan Palrasu, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 7, pp. 3560-3577
Closed Access | Times Cited: 48
Canagliflozin, a SGLT-2 inhibitor, relieves ER stress, modulates autophagy and induces apoptosis in irradiated HepG2 cells: Signal transduction between PI3K/AKT/GSK-3β/mTOR and Wnt/β-catenin pathways; in vitro
Mohamed Khairy Abdel-Rafei, Noura M. Thabet, Laila Ahmed Rashed, et al.
Journal of Cancer Research and Therapeutics (2021) Vol. 17, Iss. 6, pp. 1404-1418
Open Access | Times Cited: 41
Ketogenic diet as a treatment and prevention strategy for cancer: A therapeutic alternative
Neha Neha, Rishabh Chaudhary
Nutrition (2024) Vol. 124, pp. 112427-112427
Closed Access | Times Cited: 6
<p>Isobavachalcone isolated from <em>Psoralea corylifolia</em> inhibits cell proliferation and induces apoptosis via inhibiting the AKT/GSK-3&beta;/&beta;-catenin pathway in colorectal cancer cells</p>
Yanxi Li, Xiaoxue Qin, Penglei Li, et al.
Drug Design Development and Therapy (2019) Vol. Volume 13, pp. 1449-1460
Open Access | Times Cited: 50
The effect of a ketogenic diet and synergy with rapamycin in a mouse model of breast cancer
Yiyu Zou, Susan Fineberg, Alexander Pearlman, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0233662-e0233662
Open Access | Times Cited: 41
Anticancer effects of asiatic acid against doxorubicin-resistant breast cancer cells via an AMPK-dependent pathway in vitro
Zhu Zhu, Liao Cui, Jing Yang, et al.
Phytomedicine (2021) Vol. 92, pp. 153737-153737
Closed Access | Times Cited: 35
GSK-3β manipulates ferroptosis sensitivity by dominating iron homeostasis
Lingjuan Wang, Sijin Ouyang, Bin Li, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 34
GSK-3β Allosteric Inhibition: A Dead End or a New Pharmacological Frontier?
Beatrice Balboni, Mirco Masi, Walter Rocchia, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7541-7541
Open Access | Times Cited: 13
Nonenzymatic function of DPP4 in diabetes‐associated mitochondrial dysfunction and cognitive impairment
Cunwei Sun, Yanhua Xiao, Jiaxiu Li, et al.
Alzheimer s & Dementia (2021) Vol. 18, Iss. 5, pp. 966-987
Closed Access | Times Cited: 32
GSK-3: a multifaceted player in acute leukemias
Alberto M. Martelli, Camilla Evangelisti, Francesca Paganelli, et al.
Leukemia (2021) Vol. 35, Iss. 7, pp. 1829-1842
Closed Access | Times Cited: 30
GNG2 acts as a tumor suppressor in breast cancer through stimulating MRAS signaling
Anjiang Zhao, Dan Li, Xiongmin Mao, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 19
New insights into the role of GSK-3β in the brain: from neurodegenerative disease to tumorigenesis
Shenjin Lai, Peng Wang, Jingru Gong, et al.
PeerJ (2023) Vol. 11, pp. e16635-e16635
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top